Tag Archives: Actavis plc (ACT)

Valeant Pharmaceuticals Intl Inc VRX

Valeant Pharmaceuticals Intl Inc (VRX), Actavis plc (ACT), Clovis Oncology Inc (CLVS): Top 3 Holdings of Redmile Group LLC

Valeant Pharmaceuticals Intl Inc (VRX), Actavis plc (ACT), Clovis Oncology Inc (CLVS): Top 3 Holdings of Redmile Group LLC

Redmile Group LLC is a fully registered professional investment advisor that works on percentage on assets under management and performance based fees. The firm has its bases in San Francisco, U.S. The SEC 13F filings of Redmile Group LLC for the period ended September 30, 2014, indicated that its top three holdings are Valeant Pharmaceuticals

Actavis plc (ACT)

Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX), Charter Communications, Inc. (CHTR): Top 3 Holdings of Ratan Capital Group

Ratan Capital Group is a hedge fund that invests in equities that show growth and are secure. The firm focuses on ensuring the safety of investor funds and employs proper knowledge and planning in all its investment activities. Ratan Capital Group submitted its SEC 13F filings for the period ended September 30, 2014, showing that

Actavis plc (ACT)

Actavis plc (ACT), Valeant Pharmaceuticals Intl Inc (VRX), VASCO Data Security International, Inc. (VDSI): Top 3 Holdings of Private Capital Management

Private Capital Management is a duly registered employee-owned investment advisor founded in 1998. The firm focuses its investments on highly profitable companies. The top three holdings of Private Capital Management, according to its SEC 13F filings for the period ended September 30, 2014, are Actavis plc (NYSE:ACT), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), VASCO Data Security

Actavis plc (ACT)

Actavis PLC (ACT), AbbVie Inc (ABBV), Allergan, Inc. (AGN): Top 3 Holdings of Oz Management

Oz Management is a privately-owned hedge fund manager that also offers alternative asset management services to clients across the globe. The firm provides its management services to different entities, including corporations, funds, collateralized loan obligations, and more. Oz Management recently submitted its SEC 13F filings for the period ended September 30, 2014. The filings showed

Actavis plc (ACT)

Actavis PLC (ACT), Air Products & Chemicals, Inc. (APD), H & R Block Inc (HRB): Top 3 Holdings of Oskie Capital Management LLC

Oskie Capital Management LLC is a large investment advisory and management firm that charges performance based fees on its services. The firm has its headquarters in New York City. The SEC 13F filings of Oskie Capital Management LLC for the quarter ended September 30, 2014, showed that its three main investments are Actavis PLC (NYSE:ACT),

Dow Chemical Company (DOW)

Dow Chemical Co (DOW), Ally Financial Inc (ALLY), Actavis plc (ACT): Top 3 Stock Holdings of Third Point LLC

Dan Loeb is the fund manager for Third Point LLC and the investment practices of the investment firm go back nearly 20 years. As per the recent SEC 13F filing of Third Point LLC on November 14, Dow Chemical Co (NYSE:DOW), Ally Financial Inc (NYSE:ALLY), Actavis plc (NYSE:ACT) are its three primary stock holdings. Dow

Allergan (AGN)

Allergan, Inc. (AGN)’s Board Of Directors Give Consent For Actavis PLC (ACT) Merger

Both Allergan, Inc. (NYSE:AGN) and Actavis plc (NYSE:ACT) have come together to form one of the biggest pharmaceutical companies of the world with projected pro forma revenue of $23 billion in 2015. Under the current offer, Allergan would receive $66 billion in cash and shares of Actavis. The combined company would be able to market

Allergan (AGN)

Allergan, Inc. (NYSE:AGN) Close to $65 Billion Buyout by Actavis Plc (NYSE:ACT)

Botox maker Allergan, Inc. (NYSE:AGN) is close to completing a deal with Actavis Plc (NYSE:ACT) in a buy-out transaction amounting to about $65.5 billion. A report by Reuters, citing unnamed sources, indicates that Actavis puts Allergan shares at the range of $215 – $220, and the final price is likely to be on the higher

Actavis plc (ACT)

Actavis plc (ACT) Has A New Merger Plan for Allergan, Inc. (AGN)

After battling with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to avoid a takeover, Allergan, Inc. (NYSE:AGN) should prepare itself for a takeover possibility from Actavis plc (NYSE:ACT). According to the sources, Actavis is likely to approach Allergan for a potential merger. This is not the first time when Actavis plc (NYSE:ACT) has initiated similar efforts and

AbbVie Inc (ABBV), Perrigo Company plc Ordinary Shares (PRGO), Actavis plc (ACT) and Mallinckrodt PLC (MNK): Cramer’s Favorite Drug Manufacturer Picks in August

AbbVie Inc (NYSE:ABBV), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Actavis plc (NYSE:ACT), Mallinckrodt PLC (NYSE:MNK) are the Cramer’s favorite Drug Manufacturers which have been recommended on Mad Money TV show on August. For AbbVie Inc (NYSE:ABBV), Cramer said, “I’m a buyer. It’s a good stock to own.” AbbVie Inc (NYSE:ABBV) has been working hard to

Top